Get started
Sunshine Biopharma Inc.Sunshine Biopharma Inc.Sunshine Biopharma Inc.

Sunshine Biopharma Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

SBFM chart


Full chart

SBFM upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪6.12 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−155.59 USD
Net income (FY)
‪−4.51 M‬ USD
Revenue (FY)
‪24.09 M‬ USD
Shares float
‪2.00 M‬
Beta (1Y)
1.77

Employees


Employees (FY)
44
Change (1Y)
−2 −4.35%
Revenue / Employee (1Y)
‪547.56 K‬ USD
Net income / Employee (1Y)
‪−102.41 K‬ USD

About Sunshine Biopharma Inc.


Sector
Health Technology
CEO
Steve N. Slilaty
Headquarters
Fort Lauderdale
Website
sunshinebiopharma.com
Founded
2006
FIGI
BBG000RVLVB7
Sunshine Biopharma, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of oncology and antiviral drugs. It is also involved in the development and commercialization of science-based nutritional supplements. The firm's product includes treatment for Coronavirus infections and anticancer drugs. The company was founded on August 31, 2006 and is headquartered in Fort Lauderdale, FL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

SBFM news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of SBFM is 2.95 USD — it has decreased by −0.33% in the past 24 hours. Watch Sunshine Biopharma Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Sunshine Biopharma Inc. stocks are traded under the ticker SBFM.
SBFM stock has risen by 11.27% compared to the previous week, the month change is a −3.77% fall, over the last year Sunshine Biopharma Inc. has showed a −99.46% decrease.
We've gathered analysts' opinions on Sunshine Biopharma Inc. future price: according to them, SBFM price has a max estimate of 15.00 USD and a min estimate of 15.00 USD. Watch SBFM chart and read a more detailed Sunshine Biopharma Inc. stock forecast: see what analysts think of Sunshine Biopharma Inc. and suggest that you do with its stocks.
SBFM reached its all-time high on Aug 2, 2011 with the price of 58,000,000.00 USD, and its all-time low was 2.11 USD and was reached on Nov 21, 2024. View more price dynamics on SBFM chart.
See other stocks reaching their highest and lowest prices.
SBFM stock is 5.52% volatile and has beta coefficient of 1.77. Track Sunshine Biopharma Inc. stock price on the chart and check out the list of the most volatile stocks — is Sunshine Biopharma Inc. there?
Today Sunshine Biopharma Inc. has the market capitalization of ‪6.12 M‬, it has increased by 17.82% over the last week.
Yes, you can track Sunshine Biopharma Inc. financials in yearly and quarterly reports right on TradingView.
Sunshine Biopharma Inc. is going to release the next earnings report on Apr 8, 2025. Keep track of upcoming events with our Earnings Calendar.
SBFM earnings for the last quarter are −0.94 USD per share, whereas the estimation was −535.00 USD resulting in a 99.82% surprise. The estimated earnings for the next quarter are 0.01 USD per share. See more details about Sunshine Biopharma Inc. earnings.
Sunshine Biopharma Inc. revenue for the last quarter amounts to ‪8.44 M‬ USD, despite the estimated figure of ‪11.80 M‬ USD. In the next quarter, revenue is expected to reach ‪12.50 M‬ USD.
SBFM net income for the last quarter is ‪−1.20 M‬ USD, while the quarter before that showed ‪−494.30 K‬ USD of net income which accounts for −142.32% change. Track more Sunshine Biopharma Inc. financial stats to get the full picture.
No, SBFM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 44.00 employees. See our rating of the largest employees — is Sunshine Biopharma Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Sunshine Biopharma Inc. EBITDA is ‪−4.42 M‬ USD, and current EBITDA margin is −19.24%. See more stats in Sunshine Biopharma Inc. financial statements.
Like other stocks, SBFM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sunshine Biopharma Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Sunshine Biopharma Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Sunshine Biopharma Inc. stock shows the sell signal. See more of Sunshine Biopharma Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.